Similar articles

• Relationship between five GWAS-identified single nucleotide polymorphisms and female breast cancer in the Chinese Han population.

  He Y, Liu H, Chen Q, Sun X, Liu C, Shao Y. He Y, et al. Tumour Biol. 2016 Jul;37(7):9739-44. doi: 10.1007/s13277-016-4795-6. Epub 2016 Jan 23. Tumour Biol. 2016. PMID: 26803517
• Genome-wide association studies and the clinic: a focus on breast cancer.

  Véron A, Blein S, Cox DG. Véron A, et al. Biomark Med. 2014;8(2):287-96. doi: 10.2217/bmm.13.121. Biomark Med. 2014. PMID: 24521025 Review.
• SNPs associated with molecular subtypes of breast cancer: on the usefulness of stratified Genome-wide Association Studies (GWAS) in the identification of novel susceptibility loci.

  Kristensen VN, Børresen-Dale AL. Kristensen VN, et al. Mol Oncol. 2008 Jun;2(1):12-5. doi: 10.1016/j.molonc.2008.02.003. Epub 2008 Mar 6. Mol Oncol. 2008. PMID: 19383324 Free PMC article. No abstract available.
• GWAS in the SIGNAL/PHARE clinical cohort restricts the association between the FGFR2 locus and estrogen receptor status to HER2-negative breast cancer patients.

  Cox DG, Curtit E, Romieu G, Fumoleau P, Rios M, Bonnefoi H, Bachelot T, Soulié P, Jouannaud C, Bourgeois H, Petit T, Tennevet I, Assouline D, Mathieu MC, Jacquin JP, Lavau-Denes S, Darut-Jouve A, Ferrero JM, Tarpin C, Lévy C, Delecroix V, Trillet-Lenoir V, Cojocarasu O, Meunier J, Pierga JY, Faure-Mercier C, Blanché H, Sahbatou M, Boland A, Bacq D, Besse C, Deleuze JF, Pauporté I, Thomas G, Pivot X. Cox DG, et al. Oncotarget. 2016 Nov 22;7(47):77358-77364. doi: 10.18632/oncotarget.12669. Oncotarget. 2016. PMID: 27764800 Free PMC article.
• From candidate gene studies to GWAS and post-GWAS analyses in breast cancer.

  Fachal L, Dunning AM. Fachal L, et al. Curr Opin Genet Dev. 2015 Feb;30:32-41. doi: 10.1016/j.gde.2015.01.004. Epub 2015 Feb 27. Curr Opin Genet Dev. 2015. PMID: 25727315 Review.